Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Azilsartan Medoxomil.

Client Email

Product

Azilsartan Medoxomil
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Azilsartan Medoxomil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 15 USDMF, 10 JDMF, 10 EU WC, 15 KDMF, 6 NDC API, 37 Listed Suppliers, $ API Reference Price

56 API Suppliers
15 USDMF
10 JDMF
10 EU WC
15 KDMF
6 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

30 API Suppliers

30 API Suppliers

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 6 FDA Orange Book, 16 Europe, 4 Canada, 4 Listed Dossiers

30 FDF Dossiers
6 FDA Orange Book
16 Europe
4 Canada
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 40MG MEDOXOMIL, TABLET;ORAL - EQ 80MG MEDOXOMIL, TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG, TABLET;ORAL - EQ 40MG MEDOXOMIL;25MG

TABLET;ORAL - EQ 40MG MEDOXOMIL
TABLET;ORAL - EQ 80MG MEDOXOMIL
TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG
TABLET;ORAL - EQ 40MG MEDOXOMIL;25MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 7 Gangwal Healthcare, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 41 Fillers, Diluents & Binders, 23 Direct Compression, 21 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 12 Taste Masking, 12 Granulation, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 12 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 7 Film Formers & Plasticizers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Parenteral, 3 Rheology Modifiers, 2 Emulsifying Agents, 1 Solubilizers

44 Coating Systems & Additives
41 Fillers, Diluents & Binders
23 Direct Compression
21 Controlled & Modified Release
15 Disintegrants & Superdisintegrants
12 Taste Masking
12 Granulation
12 Thickeners and Stabilizers
12 Lubricants & Glidants
12 Chewable & Orodispersible Aids
11 Co-Processed Excipients
7 Film Formers & Plasticizers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Parenteral
3 Rheology Modifiers
2 Emulsifying Agents
1 Solubilizers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
10 Finished Drug Prices
8 Annual Reports

MARKET PLACE

15 APIs

15 APIs

PATENTS & EXCLUSIVITIES

16 US Patents, 2 Health Canada Patents

16 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

10 Others

10 Others

$ API Ref.Price (USD/KG) : 1,662 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Bausch Health, Canada Inc.

filter Patent Reset all filters

2 All

01 22557538

filter Product Reset all filters

2 All

01 2Azilsartan Medoxomil

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 22025-02-23

US Patents
Health Canada Patents

Product Main Page

01

Bausch Health, Canada Inc.

Azilsartan

Discovery on Target

Not Confirmed

Bausch Health, Canada Inc.

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

Brand Name : EDARBI

Patent Number : 2557538

Filing Date : 2005-02-23

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bausch Health, Canada Inc.

Azilsartan

Discovery on Target

Not Confirmed

Bausch Health, Canada Inc.

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

Brand Name : EDARBI

Patent Number : 2557538

Filing Date : 2005-02-23

Strength per Unit : 80 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?